August 17, 2012
OncoTherapy Science announced on August 13 that a third-party data and safety monitoring committee has confirmed the safety of the peptide-cocktail cancer vaccine OCV-C01 in a PIII trial for pancreatic cancer conducted jointly with Otsuka Pharmaceutical in Japan. Since the...read more